A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings
MITIGATE
2 other identifiers
interventional
257
1 country
3
Brief Summary
Inappropriate antibiotic use is a major public health concern. Excessive exposure to antibiotics results in emergence and spread of drug-resistant bacteria, potentially avoidable adverse drug reactions, and increased healthcare utilization and cost. As antibiotic prescribing in emergency departments and urgent care centers remains unchecked, national professional organizations including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology (SHEA), and an Executive Order from the President of the United States, recommend expansion of antimicrobial stewardship to these ambulatory care settings. The goal of antimicrobial stewardship is to effectively promote judicious antibiotic use in all healthcare settings, yet stewardship programs have not achieved their potential in terms of either reach or effectiveness. Reach has been limited by implementation mostly in inpatient settings; at the same time, recent critical experiments in behavioral science suggest that the effectiveness of existing stewardship programs could be greatly augmented through inclusion of behavioral nudges, benchmarked audit and feedback, and peer-to-peer comparisons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 11, 2017
CompletedFirst Posted
Study publicly available on registry
January 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 24, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 24, 2018
CompletedDecember 20, 2018
December 1, 2018
1.7 years
January 11, 2017
December 18, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Antibiotic Prescribing Trends
The investigators will measure the likelihood that an antibiotic is prescribed in an antibiotic-nonresponsive acute respiratory infection visit.
Up to 2 years
Study Arms (2)
Adapted Intervention
NO INTERVENTIONThe investigators will use GetSmart materials published by the CDC appropriate to the emergency department and urgent care settings and select and adapt brochures and other campaign messages for acute care providers.
Enhanced Intervention
EXPERIMENTALThe investigators will use all of the methods of the Adapted Intervention. In addition to these methods, the investigators will add posters within exam rooms which will include modified GetSmart content and other nudges such as physician pictures with their signed public commitment to antibiotic stewardship or flair denoting commitment to stewardship. The investigators will also provide physicians with personalized monthly performance ranking with each physician receiving the designation of "top performer" or "not a top performer" based on their appropriate antibiotic prescribing practices for acute respiratory infections. This will be the Enhanced Antimicrobial Stewardship Commitment and Feedback intervention.
Interventions
Goes beyond the GetSmart recommendations to discern whether these recommendations can be improved upon.
Eligibility Criteria
You may qualify if:
- Must be a clinician at one of the study sites.
- Must treat adult and/or pediatric patients with an acute respiratory infections.
You may not qualify if:
- Medical co-morbidities that make acute respiratory infection (ARI) guidelines less likely to apply.
- Concomitant visit diagnoses indicating a non-ARI possible bacterial infection.
- Concomitant visit diagnoses indicating potentially antibiotic appropriate ARI. diagnoses or other ARI diagnoses suggestive of a bacterial infection.
- Visit occurred within 30 days of an earlier ARI diagnosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
UC Davis Medical Center
Sacramento, California, 95817, United States
UCLA Harbor Medical Center
Torrance, California, 90509, United States
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larissa S May, MD,MSPH,MSHS
Associate Professor and Director of Emergency Department Antibiotic Stewardship
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2017
First Posted
January 18, 2017
Study Start
January 1, 2017
Primary Completion
September 24, 2018
Study Completion
September 24, 2018
Last Updated
December 20, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share
No IPD planned.